PMC:7317273 / 7064-7272 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T38","span":{"begin":185,"end":190},"obj":"Body_part"},{"id":"T39","span":{"begin":195,"end":199},"obj":"Body_part"}],"attributes":[{"id":"A38","pred":"fma_id","subj":"T38","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A39","pred":"fma_id","subj":"T39","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"They show clonogenicity, and higher ex-vivo proliferative capacity [10] compared with MSCs; they are less prone to malignancy [11], and therefore can give rise to sufficient numbers of cells for cell therapy."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T60","span":{"begin":127,"end":129},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T61","span":{"begin":185,"end":190},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T62","span":{"begin":195,"end":199},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"They show clonogenicity, and higher ex-vivo proliferative capacity [10] compared with MSCs; they are less prone to malignancy [11], and therefore can give rise to sufficient numbers of cells for cell therapy."}

{"project":"LitCovid-PubTator","denotations":[{"id":"238","span":{"begin":115,"end":125},"obj":"Disease"}],"attributes":[{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"They show clonogenicity, and higher ex-vivo proliferative capacity [10] compared with MSCs; they are less prone to malignancy [11], and therefore can give rise to sufficient numbers of cells for cell therapy."}

{"project":"LitCovid-sentences","denotations":[{"id":"T42","span":{"begin":0,"end":208},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"They show clonogenicity, and higher ex-vivo proliferative capacity [10] compared with MSCs; they are less prone to malignancy [11], and therefore can give rise to sufficient numbers of cells for cell therapy."}

{"project":"2_test","denotations":[{"id":"32592163-22566051-140679175","span":{"begin":68,"end":70},"obj":"22566051"},{"id":"32592163-26032749-140679176","span":{"begin":127,"end":129},"obj":"26032749"}],"text":"They show clonogenicity, and higher ex-vivo proliferative capacity [10] compared with MSCs; they are less prone to malignancy [11], and therefore can give rise to sufficient numbers of cells for cell therapy."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T105","span":{"begin":86,"end":90},"obj":"DG_47"},{"id":"T4399","span":{"begin":86,"end":90},"obj":"DG_47"}],"text":"They show clonogenicity, and higher ex-vivo proliferative capacity [10] compared with MSCs; they are less prone to malignancy [11], and therefore can give rise to sufficient numbers of cells for cell therapy."}